FDA
approval
· 2022-11-10
FDA Approved: LILETTA — Supplemental Application (Allergan, Inc.)
Summary
FDA approved a supplemental application for LILETTA (levonorgestrel) submitted by Allergan, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LILETTA (LEVONORGESTREL)